A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/8547862

Download in:

View as

General Info

PMID
8547862